secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2026-06-11T21:00:26+00:00
Accession:  0001493152-26-028301
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals announces 1-for-10 reverse stock split effective June 11, 2026
--------------------------------------------------------------------------------

- Board approved 1:10 reverse split of common stock, effective June 11, 2026.
- Every ten pre-split shares combine into one; no fractional shares issued (round up to whole share).
- Authorized shares unchanged; exercise prices of warrants, RSUs, and convertible preferred adjusted proportionally.
- New CUSIP number for post-split common stock is 825693500.
- Stockholders' approval obtained at annual meeting on May 21, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226028301/0001493152-26-028301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226028301/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer